Bayesian Adaptive Randomized Trial Design for Patients With Recurrent Glioblastoma

PURPOSE: To evaluate whether the use of Bayesian adaptive randomized (AR) designs in clinical trials for glioblastoma is feasible and would allow for more efficient trials. PATIENTS AND METHODS: We generated an adaptive randomization procedure that was retrospectively applied to primary patient data...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Trippa, Lorenzo, Lee, Eudocia Q., Wen, Patrick Y., Batchelor, Tracy T., Cloughesy, Timothy, Parmigiani, Giovanni, Alexander, Brian M.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2012
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434985/
https://ncbi.nlm.nih.gov/pubmed/22649140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.39.8420
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars